Nektar Therapeutics (ITH MU) stock market data APIs
€19.8991
0(0%)
as of July 10, 2025
Try our APIs with
free plan!
Nektar Therapeutics Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ITH.MU.
Prev. Close
19.8991
Open
19.8991
High
19.8991
Low
19.8991
52 wk Range
6.651-25.2
Market Cap
2 020 M
EPS
-0.01
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Nektar Therapeutics data using free add-ons & libraries
Get Nektar Therapeutics Fundamental Data
Nektar Therapeutics Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2018-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nektar Therapeutics News
New
Nektar Therapeutics (NASDAQ:NKTR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
The analysts might have been a bit too bullish on Nektar Therapeutics (NASDAQ:NKTR), given that the company fell short of expectations when it released its quarterly results last week. Statutory earni...
Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference
SAN FRANCISCO, May 13, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual BioConnect Inve...
Time To Worry? Analysts Are Downgrading Their Nektar Therapeutics (NASDAQ:NKTR) Outlook
One thing we could say about the analysts on Nektar Therapeutics (NASDAQ:NKTR) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the org...
Nektar Therapeutics First Quarter 2025 Earnings: Misses Expectations
Nektar Therapeutics (NASDAQ:NKTR) First Quarter 2025 Results Key Financial Results Revenue: US$10.5m (down 52% from 1Q 2024). Net loss: US$50.9m (loss widened by 38% from 1Q 2024). US$0.24 loss per ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
